SCHEMBL20174327

SCHEMBL20174327

c1ccc(-c2ccc(-c3cc(-c4cccc5c4-c4c(oc6ccccc46)C54c5ccccc5-c5ccccc54)cc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.34
MAPK1 P28482 2/20 0.32
KMT2A Q03164 2/20 0.32
ALOX5 P09917 2/20 0.32
DHODH Q02127 1/20 0.32
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
ACACA Q13085 1/20 0.30
MYC P01106 1/20 0.30
AKT1 P31749 1/20 0.30
AKT2 P31751 1/20 0.30
AKT3 Q9Y243 1/20 0.30
ADORA2A P29274 1/20 0.30
ADORA1 P30542 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174360 0.92 ENPP3 (0.34) PDK2MAPK1KMT2AMEN1ALDH1A1
SCHEMBL20174346 0.91 KMT2A (0.36) MAPK1KMT2AMEN1ALDH1A1MAPT
SCHEMBL20174333 0.91 KMT2A (0.33) PDK2MAPK1KMT2AALOX5DHODH
SCHEMBL20174310 0.90 KMT2A (0.37) MAPK1KMT2AMEN1ALDH1A1MAPT
SCHEMBL20174367 0.89 KMT2A (0.37) MAPK1KMT2AALOX5PLA2G2APLA2G4A
SCHEMBL20174344 0.89 KMT2A (0.37) MAPK1KMT2AALOX5PLA2G2APLA2G4A
SCHEMBL20174325 0.88 KMT2A (0.36) MAPK1KMT2AALOX5MEN1ALDH1A1
SCHEMBL20174392 0.87 KMT2A (0.36) MAPK1KMT2APLA2G2APLA2G4AMEN1
SCHEMBL20174328 0.87 PDK2 (0.38) PDK2MAPK1KMT2APLA2G2APLA2G4A
SCHEMBL20174424 0.87 ACACA (0.38) MAPK1DHODHALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG PDK2 651/4885MAPK1 3742/4885KMT2A 1480/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG PDK2 651/4885MAPK1 3742/4885KMT2A 1480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.